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Background: Bone mineral density (BMD) measurements are frequently performed repeatedly for each
patient. Subsequent BMD measurements allow reproducibility to be assessed.
Objective: To examine the reproducibility of BMD by dual energy x ray absorptiometry (DXA) and to
investigate the practical value of different measures of reproducibility in a group of postmenopausal
women.
Methods: Ninety five women, mean age 59.9 years, underwent two subsequent BMD measurements of
spine and hip. Reproducibility was expressed as smallest detectable difference (SDD), coefficient of
variation (CV), and intraclass correlation coefficient (ICC). Sources of variation were investigated by
multilevel analysis.
Results: The median interval between measurements was 0 days (range 0–45). The mean difference (SD)
between the measurements (g/cm2) was 20.001 (0.02) and 20.0004 (0.02) at L1-4 and the total hip,
respectively. At L1-4 and the total hip, SDD (g/cm2) was ¡0.05 and ¡0.04 and CV (%) was 1.92 and
1.59, respectively. The ICC at spine and hip was 0.99.
Conclusions: Reproducibility in the postmenopausal women studied was good. In a repeated DXA scan a
BMD change exceeding 2!2CV (%), the least significant change (LSC), or the SDD should be regarded as
significant. Use of the SDD is preferable to use of the CV and LSC (%) because of its independence from
BMD and its expression in absolute units. Expressed as SDD, a BMD change of at least ¡0.05 g/cm2 at
L1-4 and ¡0.04 g/cm2 at the total hip should be considered significant.
B
one densitometry was developed for diagnosis and treat-
ment evaluation of osteoporosis. Dual energy x ray
absorptiometry (DXA) is the most widely used modality
for bone mineral density (BMD) measurement.1 2 The defini-
tions of osteopenia and osteoporosis, as proposed by the WHO,
are based on results of DXA measurements.3 Meanwhile,
therapeutic options for treatment of osteoporosis have been
developed which create possibilities of effective intervention.
Therefore, screening for and treatment of osteoporosis are
widely practised in postmenopausal women and in people
with an increased risk of osteoporosis because of underlying
diseases.4 5 It has become more and more common practice to
perform a second DXA measurement to monitor BMD status
or the effect of therapeutic intervention, even though BMD is
a surrogate for fracture risk. The reproducibility of DXA mea-
surements—that is, the ability of an instrument to reproduce
the same results in several measurements, is claimed to be
good. Precision, expressed as percentages, of phantom mea-
surements is around 0.5%. In in vivo studies in healthy young
people, these figures range from 0.6 to 1.4, depending on
machine type, study group, and measurement site.6–8
When a second measurement is performed on a patient,
the BMD change is considered statistically relevant if it
exceeds at least twice the precision error of the measure-
ment.9–11 Despite the abundance of publications on BMD
variability in different patient groups, only limited data from
postmenopausal women, the patients commonly considered
for BMD measurement, are available on short term BMD
variability.6 12 13 Note that reproducibility studies established
by pre- and post-measurements are different from repeated
measurements studies of BMD where the prime focus is on
change in BMD as opposed to measurement variability.
The precision error is usually expressed as the coefficient of
variation (CV),14–16 although several other statistics to express
reproducibility exist and other measures, such as the smallest
detectable difference (SDD), may be preferable to the CV.13 17
Data on potential sources of measurement variability, related
to the device, technician, or patient, show conflicting
results.13 18 19 For example, BMD measurement error was
independent of age in one study,18 whereas others found
greater measurement error in older osteoporotic subjects13 or
reproducibility dependent on age related factors other than
BMD.19 Therefore, we investigated short term variability, the
practical significance of different measures of variability, and
the sources of variability in postmenopausal women in a
university hospital. In addition, short term variation in a
limited number of children was investigated because
measurements on bone density in children are more often
performed than in the past and precision in this group is
assumed to be better than in adults.2 20
METHODS
Subjects
The subjects were recruited in one centre from participants in
four studies. The first three of these studies concerned ran-
domised clinical trials on the effects of the selective oestrogen
receptor modulator raloxifene.21–23 During two months in
1998, consecutive postmenopausal women undergoing a
BMD measurement of lumbar spine and femur who had
had several BMD measurements in the past (that is, between
July 1994 and June 1997) were recruited. The maximum
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Abbreviations: BMD, bone mineral density; BMI, body mass index; CV,
coefficient of variation; DXA, dual energy x ray absorptiometry; ICC,
intraclass correlation coefficient; LSC, least significant change; SDD,
smallest detectable difference
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interval between the two DXA measurements was 45 days. A
change in BMD was not expected during this interval.
At the same time girls participating in a local study on the
effects of puberty on BMD had their BMD measured twice.24
Ethics
All four study protocols were approved by the local medical
ethics committee.
Methodology of BMD measurement
All BMD measurements were performed on a Hologic QDR
2000 machine (Hologic Inc, Waltham, Massachusetts). The
software version used was V4.7. The DXA scans were
obtained by standard procedures supplied by the manufac-
turer for scanning and analysis. The compare feature was
used for the second scan. No records were kept of difficulties
observed in the positioning of patients. Plain x rays
documenting the presence of arthritic changes were not
used. Daily quality control was carried out by measurement
of a Hologic anthropomorphic spine phantom. At the time of
the duplo measurements, phantom measurements showed
stable results. The phantom precision expressed as the CV
(%) was 0.82. The BMD measurements were carried out by
experienced technicians.
Patient BMD was measured at the lumbar spine (L1-4)
(posteroanterior projection) and at the left femur. At the
femur the following sites were studied: total hip, femoral
neck, and trochanter. When the two measurements were
made on the same day, the patient was completely reposi-
tioned after the initial measurement.
T and Z scores were calculated using the reference
population provided by the manufacturer. In the T score,
the patient’s BMD value is expressed as SD as compared with
the mean BMD of a reference population of young adults. For
Z score calculation, the patient’s BMD is compared with the
mean BMD of people of the same sex and age and also
expressed as SD.
DBMD and the DT score were calculated by subtracting the
results of the second measurement from the results of the
first. The range of the difference in BMD as a percentage was
calculated by dividing the difference between the first (a) and
the second (b) measurement by the mean of those two
figures, giving the fraction of difference between the two
measurements as compared with the mean of the two
measurements. The normally distributed variables are pre-
sented as mean (SD).
Precision
The measurement error was calculated using Bland and
Altman’s 95% limits of agreement method. Other methods
used to evaluate reliability and agreement are also described.
These are the CV and the intraclass correlation coefficient
(ICC).
Precision expressed according to the Bland and Altman’s
95% limits of agreement method25 gives an absolute and
metric estimate of random measurement error, also called
SDD. In this case, where there are two observations for each
subject, the standard deviation of the differences (SDdiff )
estimates the within variability of the measurements. Most
disagreements between measurements are expected to be
between limits called ‘‘limits of agreement’’ defined as
d¡z(1-a/2) SDdiff where d is the mean difference between
the pairs of measurements and z(1-a/2) is the 100(1-a/2)th
centile of the normal distribution.25 The value d is an estimate
of the mean systematic bias of measurement 1 to measure-
ment 2. d is expected to be 0 because we do not assume a true
change in BMD to occur during the interval between the two
BMD measurements. Defining a to be 5%, the limits of
agreement are +1.96SDdiff and21.96SDdiff. Thus, about twice
the standard deviation (SD) of the difference scores gives the
95% limits of agreement for the two measurements by the
machine. A test is considered to be capable of detecting a
difference, in absolute units, of at least the magnitude of the
limits of agreement.
The CV, the most commonly presented measure for BMD
variability, is the SD corrected for the mean of paired
measurements. CV, expressed as a percentage, was calculated
as CV% = (!((g(a2b)2)/2n))/((Ma+Mb)/2)6100 where a and
b are the first and the second measurement, Ma and Mb are
the mean values for the two groups, and n is the number of
paired observations.26 For two point measurements in time, a
BMD change exceeding 2!2 times the precision error of the
technique is considered a significant change (with 95%
confidence).9 Gluer et al called this smallest change that is
considered statistically significant, the least significant
change (LSC).11 In the current study, the LSC (%) was
computed for the different BMD measurement sites. In these
calculations the precision error is expressed as the CV (%).
The ICC equals variance between patients divided by
variance between patients plus variance between measure-
ments. The value of the ICC ranges from 0 to 1, 1 representing
perfect reliability of the measurement.
Multi level analysis of variability
Because multiple linear regression analysis does not allow us
to discern whether the observed variation in BMD is
attributable to individual differences between patients or to
the influence of interval length, multilevel analysis was
used.27 Multilevel analysis can separate and quantify indivi-
dual variability in contrast with measurement of interval
length variability. The models used were two level variance
component models, with measurement interval at the first
level and patients at the second level. Demographic vari-
ables—for example, age (years) and body mass index (BMI)
(kg/m2), and BMD variables, such as area (cm2) of BMD
measurement and technician identity, were included as
sources of BMD variability—that is, possible confounders
that need correction. Separate models were used for different
measurement sites. The fixed parameters in the final models
describe the average contribution of each confounder.
Patients with their corresponding interval between measure-
ments will vary around the predictive value of the model. The
degree of variation at patient level and at interval level is
estimated in the random part of the model.
Statistical analysis was carried out using SPSS, version 9.0
(SPSS, Chicago, Illinois) and MLwiN for multilevel analysis.28
RESULTS
Postmenopausal women
Patient characterist ics
The BMD measurements of 95 postmenopausal women were
collected during the recruitment period. The mean (SD) age
of the women was 59.9 (8.1) years. Their mean (SD) height
was 163.7 (6.6) cm and their mean (SD) weight 68.8
(10.5) kg. The mean (SD) BMI was 25.7 (3.8) (kg/m2). The
interval between the first and the second spine and hip DXA
ranged between 0 and 45 days, with a median of 0 days.
Table 1 shows the BMD data and the derived T and Z score
data for each measurement site. The mean (SD) difference
between the first and the second measurement (g/cm2) was
20.001 (0.02) at L1-4 and 20.0004 (0.02) at the total hip.
The mean (SD) T scores of the first measurement were 21.59
(1.50) and 21.34 (1.26) at L1-4 and total hip, respectively.
Some patients had T scores far below 22.5 SD. The range of
the difference between the T score of the first and the second
BMD measurement was 20.42 to +1.30 at L1-4 and 21.84 to
+0.60 at the total hip.
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Variability
Table 2 presents the results of the various methods of
calculating variability for the three most frequently used
measurement sites. Figures 1 and 2 show the scatter plots of
the difference between the two measurements against their
mean, for lumbar spine and total hip. The horizontal lines in
these graphs show the mean of the differences and the limits
of agreement. When Bland and Altman’s 95% limits of
agreement method was used, the mean of the difference
scores approached zero, reflecting no systematic bias between
measurements (the 95% CI included zero difference). In this
method, random measurement error, is expressed as SD of
the difference scores. Twice this value approaches the 95%
limits of agreement. Thus, for the total hip the SDD in BMD
measurements based on two BMD values with a short
interval is 0.04 g/cm2. The SDD at the spine was 0.05 g/cm2.
The CV (%) was 1.59 at the total hip and 1.92 at the spine.
The LSC (%) was 4.50 and 5.43 at the total hip and at the
spine, respectively. Therefore, in an individual subject a BMD
change at the total hip can be considered significant if the
change between the measurements exceeds the SDD (expres-
sed in absolute units) of 0.04 g/cm2 or the LSC (%) of 4.50%.
Reliability expressed by ICC was 0.99 with narrow 95%
confidence intervals at all measurement sites.
Multilevel analysis
The fixed part of the final model for the spine (L1-4), apart
from the constant, contained the variables technician, age,
and area of BMD measurement. Both age and area predict
BMD, though these variables do not influence BMD
variability. The random part of the model shows that most
of the variance in BMD (98.6%) can be attributed to the
patients, whereas only 0.7% can be attributed to interval
length. The percentage variance attributed to the technician
is also 0.7%. In the final model for the trochanter, age and
BMI are predictors of BMD. For the femoral neck, predictors
were age and area. Finally, the model for total hip included
age, BMI, and technician. Age was the only negatively
correlated variable in the fixed part of each model. At all
Table 1 BMD, T, and Z scores in postmenopausal women (n = 95)
L1-4 Total hip Femoral neck Trochanter
Mean BMD (g/cm2) (a) 0.87 (0.17) 0.82 (0.15) 0.69 (0.13) 0.63 (0.13)
Range BMD (g/cm2) (a) 0.49 to 1.22 0.48 to 1.20 0.37 to 1.12 0.33 to 0.97
Mean DBMD (g/cm2) (a2b) 20.001 (0.02) 20.0004 (0.02) 20.0008 (0.02) 20.0006 (0.01)
Range DBMD (g/cm2) (a2b) 20.05 to 0.14 20.04 to 0.07 20.06 to 0.09 20.03 to 0.05
Range DBMD (%)* 26.6 to 14.9 26.2 to 7.6 212.7 to 13.1 27.6 to 6.1
Mean T score (a) 21.59 (1.50) 21.34 (1.26) 22.06 (1.33) 21.07 (1.40)
Range T score (a) 25.08 to 1.54 24.09 to 1.86 25.27 to 2.26 24.32 to 2.71
Mean DT score (a2b) 20.01 (0.22) 20.02 (0.24) 20.007 (0.22) 20.006 (0.15)
Range DT score (a2b) 20.42 to 1.30 21.84 to 0.60 20.60 to 0.91 20.35 to 0.51
Mean Z score (a) 20.19 (1.35) 20.27 (1.10) 20.44 (1.18) 20.04 (1.28)
Range Z score (a) 23.40 to 2.47 22.81 to 2.54 23.40 to 3.66 23.46 to 3.32
Mean (SD) for normally distributed variables. (a) First BMD measurement; (b) second BMD measurement.
*Formula: (a2b)/(a+b/2)6100.
Table 2 Reproducibility of BMD (g/cm2) measurement in postmenopausal women (n = 95) and children (n = 23)
Postmenopausal women Children
L1–4 Femoral neck Total hip L1–4 Femoral neck Total hip
Bland and Altman’s methods
Mean difference (95% CI)
(systematic bias)
20.001
(20.05 to 0.05)
20.0008
(20.04 to 0.04)
20.0004
(20.04 to 0.04)
20.0009
(20.02 to 0.02)
20.004
(20.05 to 0.04)
20.003
(20.03 to 0.02)
SD difference 0.0238 0.0220 0.0184 0.0088 0.0122 0.0116
(random measurement error)
SDD ,95% limits of agreement ¡0.0466 ¡0.0432 ¡0.0361 ¡0.0172 ¡0.0238 ¡0.0228
(assuming no systematic bias)
CV (%) 1.92 2.25 1.59 0.84 1.34 1.19
LSC (%) 5.43 6.36 4.50 2.38 3.79 3.37
Random effects ICC
(95% CI)
0.99 (0.98 to 0.99) 0.99 (0.98 to 0.99) 0.99 (0.99 to 0.99) 0.99 (0.99 to 1.00) 0.99 (0.97 to 1.00) 0.99 (0.99 to 1.00)
Mean difference, mean of the difference between the first and the second BMD measurement; SD difference, SD of the difference between the first and the second BMD
measurement; SDD, smallest detectable difference (g/cm2); CV, coefficient of variation (%); LSC, least significant change (%); ICC, intraclass correlation coefficient.
SD difference and SDD are rounded off to two decimal places in the text of the article.
Figure 1 Graph of the difference score against the mean score of the
two total hip BMD measurements (g/cm2) in postmenopausal women
(open diamonds) and children (closed squares). The outermost (solid)
lines represent the 95% limits of agreement for postmenopausal women.
The inner (dashed) lines represent the 95% limits of agreement for
children.
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measurement sites in the hip, BMD variation is mainly
explained by patient variability in BMD; the interval between
measurements and technician variation in the case of the
total hip explain only a small part of BMD variation (figures
not shown).
Children
Patient characterist ics
The mean (SD) age of the 23 girls investigated was 11.2 (1.3)
years. In each girl, the first and second BMD measurements
were carried out on the same day, with complete reposition-
ing between the two measurements. The mean (SD) of the
first BMD measurement (g/cm2) was 0.72 (0.11) at the spine,
0.66 (0.08) at the femoral neck, and 0.70 (0.11) at the total
hip. Although the mean of the difference in BMD values for
the children was of the same order as for the postmenopausal
women, the SD and the range of the difference were smaller
in children than in the postmenopausal women. At the
lumbar spine, for example, the mean (SD) of the difference
between the two measurements was 20.0009 (0.009) (range
20.03 to +0.01) in children, whereas these figures were
20.001 (0.02) (range 20.05 to +0.14) in the women. At the
total hip these figures were 20.003 (0.01) (range 20.04 to
+0.02) in children and20.0004 (0.02) (range20.04 to +0.07)
in the postmenopausal women, respectively.
Variability
Table 2 and figs 1 and 2 show that the SDD tended to be
smaller in the children than in the women.
In the children CV% at L1-4 and the total hip were 0.84 and
1.19, whereas in the postmenopausal women these figures
were 1.92 and 1.59, respectively. Consequently, the LSC in
children is smaller. Hence, as compared with the women, a
smaller change in BMD can be regarded as a significant
change.
The ICC was as high in the children as in the postmeno-
pausal women (table 2).
Multilevel analysis
The group of children described was considered too small for
multilevel analysis to be performed.
DISCUSSION
This study shows the in vivo short term variability of BMD
measurement by DXA in a group of postmenopausal women
with a wide range of BMD values. In the group of women
studied, reproducibility expressed by different means is good.
The clinician interpreting a repeated DXA scan of a subject
should be aware that a BMD change exceeding the LSC is
significant, here arising from a BMD change of at least 4.5%
at the total hip and 5.4% at the spine. Expressed as SDD, a
BMD change should exceed 0.04 g/cm2 at the total hip and
0.05 g/cm2 at the spine before it can be considered a
significant change.
Despite the many publications on BMD variability in diffe-
rent patient groups, only limited data from a large number of
postmenopausal women are available on short term BMD
variability.6 12 13 In the reports published, variability is usually
expressed as CV and the figures for short term variability are
lower than the ones we found.6–8 Two studies showed varia-
bility data more in line with our results.13 29 Two samples of
healthy (n = 70) and elderly (n = 57) postmenopausal women
showed a CV (%) of 0.9 and 1.8, respectively, at the spine,
and of 0.9 and 2.3, respectively, at the total hip.13 Eastell
showed an LSC (%) of 5.4 at the lumbar spine and 8 at the
femoral neck, respectively, in osteoporotic postmenopausal
women.29 The varying results of reproducibility studies might
be explained by the ‘‘population’’ investigated; a phantom
and healthy young subjects are likely to show more favour-
able variability than postmenopausal women, possibly in part
because of easier positioning for measurement. The current
study also shows better variability, expressed as CV (%), in
children. Secondly, osteoarthritis in postmenopausal women
may contribute to poorer variability than found in healthy
young subjects. Besides, the majority of the studies men-
tioned had small patient samples, giving less precise results.
Alternative measures of variability are the SDD and ICC.
The Bland and Altman plots visualise between measurement
differences. The scatter plots of the current data show a
random distribution of values, indicating the absence of a
relationship between the measurement error and the true
BMD value, as estimated by the mean of the two measure-
ments. The SDD values found in the adult patients were
slightly higher than the figures presented by Ravaud et al.13 In
the first group of postmenopausal women (mean age 53
years) they describe, the SDD was 0.02 (g/cm2) at the total
hip and 0.02 at the lumbar spine. In the second group
described, women with a mean age of 80 years, these figures
were 0.04 and 0.04, respectively. The SDD values of the
children studied tended to be lower than the values in the
postmenopausal women. Using the SDD one can state that a
(BMD) change larger than the figure found is a true (BMD)
change in 95% of the cases. The characteristics of the Bland
and Altman method thus allow direct insight into the
variability of the measurement under study. Previously
published reports,13 30 as well the current data, show that
reproducibility expressed in absolute units (SDD) is inde-
pendent of the BMD value. Reproducibility expressed as a
percentage (CV) and the derived LSC, however, depend on
the BMD value. Because of therapeutic consequences, the
clinician should be especially careful in judging an apparent
BMD change in patients with osteoporosis. The use of the
SDD in the evaluation of an apparent BMD change gives a
more conservative approach than the use of the CV at low
BMD. Because of its independence from the BMD level and
its expression in absolute units, the SDD is a preferable
measure for use in daily clinical practice as compared with
the CV and the derived LSC.
The ICC found in postmenopausal women and children
was high, indicating good overall reproducibility of BMD
measured by DXA. However, it is important to note that a
Figure 2 Graph of the difference score against the mean score of the
two lumbar spine BMD measurements (g/cm2) in postmenopausal
women (open diamonds) and children (closed squares). The outermost
(solid) lines represent the 95% limits of agreement for postmenopausal
women. The inner (dashed) lines represent the 95% limits of agreement
for children.
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large variability between patients automatically increases the
ICC. The ICC and the Bland and Altman method yield
complementary information; the presence of systematic bias
cannot be found by estimating ICC.
Although the variability as expressed by the ICC, and
especially the SDD, is reassuring, showing good short term
variability at group level, the wide range of the differences in
BMD and the derived T scores indicates considerable
individual differences between two consecutive BMD mea-
surements in some patients. The range in DT scores, for
example, indicates that in some patients the diagnosis, based
on the diagnostic thresholds of the WHO, would change
owing to the measurement variability. Measured as percen-
tages, differences between BMD measurements in patients
(table 1) should be interpreted with care because the
difference as a percentage depends on the mean BMD of
the two measurements. Similar BMD differences in the
numerator of the fraction can yield a different percentage
BMD change depending on the mean value of the BMD in the
denominator of the fraction.
Before investigating sources of raw BMD variation we
considered examining sources of DBMD variation. However,
technician variability in DBMD could not be assessed because
in some cases different technicians carried out the two
consecutive DXA scans. To our knowledge, this is the first
study using multilevel analysis to investigate the sources of
BMD variation. It is difficult to interpret why the variable
technician predicts BMD only at the spine and the total hip.
Why area predicts BMD at the spine and femoral neck and
not at the other measurement sites is also hard to under-
stand. The well known determinants of BMD, age and BMI,
are also found in this study. BMD variation was mainly
explained by patient variability, while interval length and
technician in the case of the spine and total hip only explain a
small part of the BMD variation. The local technicians thus
have negligible influence on BMD variation. Whether this
applies to other centres remains a question to be answered at
the individual centre.
It should be noted that the presented variability figures
hold exclusively for this patient group and this particular
DXA device in our hands. The figures show that at our centre
the favourable variability values presented in the literature
cannot be reproduced in daily practice in postmenopausal
women. Thus, for optimal clinical decision making, indivi-
dual centres should establish the reproducibility figures based
on routine DXA measurements in different patient groups.
In conclusion, reproducibility of BMD measurement by
DXA in postmenopausal women expressed by different
means is good at a group level. However, the clinician must
remain aware that an apparent BMD change in an individual
patient may represent a precision error. In daily practice, the
use of the SDD is preferable to the use of the CV and LSC
because of its independence from BMD level and its
expression in absolute units.
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